Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients

Transplant Immunology - Tập 18 - Trang 338-343 - 2008
Da-Yeon Jung1, Jae Berm Park2, Eun-Na Lee1, Hyun-Ah Lee1, Jae-Won Joh2, Choon Hyuck Kwon2, Chang-Seok Ki3, Soo-Youn Lee3, Sung-Joo Kim1,2
1Transplantation Research Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
2Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
3Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Tài liệu tham khảo

Giannoudis, 2004, Inflammatory serum markers in patients with multiple trauma, J Bone Jt Surg {Br}, 86, 313, 10.1302/0301-620X.86B3.15035 Mimoz, 1998, Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome, Intensive Care Med, 24, 185, 10.1007/s001340050543 Eckert, 2004, S100 proteins in the epidermis, J Invest Dermatol, 123, 23, 10.1111/j.0022-202X.2004.22719.x Brandtzaeg, 1995, The leucocyte protein L1 (calprotectin): a putative nonspecific defense factor at epithelial surfaces, Adv Exp Med Biol, 371, 201, 10.1007/978-1-4615-1941-6_41 Goebeler, 1994, Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection, Transplantation, 58, 355, 10.1097/00007890-199408000-00018 Burkhardt, 2001, An increase in myeloid-related protein serum levels precedes acute renal allograft rejection, J Am Soc Nephrol, 12, 1947, 10.1681/ASN.V1291947 Ikemoto, 2003, New ELISA system for myeloid-related protein complex (MRP 8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection, Clin Chem, 4, 594, 10.1373/49.4.594 Wanner, 2000, Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients, Crit Care Med, 28, 950, 10.1097/00003246-200004000-00007 Becker, 1996, Calcitonin: structure, molecular biology, and actions, 471 Assicot, 1993, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, 515, 10.1016/0140-6736(93)90277-N Jaresova, 1999, Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections, Immunol Lett, 69, 355, 10.1016/S0165-2478(99)00120-0 Muller, 2001, Procalcitonin: how a hormone became a marker and mediator of sepsis, Swiss Med Wkly, 20, 595 Zwadlo, 1986, A monoclonal antibody to a subset of human monocytes found only in peripheral blood and inflammatory tissues, J Immunol, 137, 512, 10.4049/jimmunol.137.2.512 Racusen, 1999, The Banff 97 working classification of renal allograft pathology, Kidney Int, 55, 713, 10.1046/j.1523-1755.1999.00299.x Kim, 2003, Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation, Transplantation, 75, 2151, 10.1097/01.TP.0000066807.91219.F7 Striz, 2001, MRP 8/14 and procalcitonin serum levels in organ transplantations, Ann Transplant, 6, 6 Oczenski, 1998, Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period, Eur J Anaesthesiol, 15, 202, 10.1111/j.0265-0215.1998.00280.x